albuterol has been researched along with Shock, Cardiogenic in 5 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nine patients with critically reduced cardiac output after acute myocardial infarction underwent a single cross-over comparison of dobutamine and salbutamol to compare the haemodynamic effects of these drugs, which have, respectively, predominantly beta 1-adrenergic and beta 2-adrenergic agonist activity." | 9.05 | Comparison of haemodynamic responses to dobutamine and salbutamol in cardiogenic shock after acute myocardial infarction. ( Chamberlain, DA; Crick, JP; Fowler, MB; Timmis, AD; Vincent, R, 1982) |
| "Nine patients with critically reduced cardiac output after acute myocardial infarction underwent a single cross-over comparison of dobutamine and salbutamol to compare the haemodynamic effects of these drugs, which have, respectively, predominantly beta 1-adrenergic and beta 2-adrenergic agonist activity." | 5.05 | Comparison of haemodynamic responses to dobutamine and salbutamol in cardiogenic shock after acute myocardial infarction. ( Chamberlain, DA; Crick, JP; Fowler, MB; Timmis, AD; Vincent, R, 1982) |
| "Salbutamol may be useful in the treatment of cardiogenic shock and pump failure complicating acute myocardial infarction." | 1.26 | Salbutamol in cardiogenic shock complicating acute myocardial infarction. ( Dawson, JR; Poole-Wilson, PA; Sutton, GC, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Henderson, A | 1 |
| Timmis, AD | 3 |
| Fowler, MB | 2 |
| Chamberlain, DA | 3 |
| Crick, JP | 1 |
| Vincent, R | 1 |
| Dawson, JR | 1 |
| Poole-Wilson, PA | 1 |
| Sutton, GC | 1 |
| Strak, SK | 1 |
2 trials available for albuterol and Shock, Cardiogenic
| Article | Year |
|---|---|
Comparison of haemodynamic responses to dopamine and salbutamol in severe cardiogenic shock complicating acute myocardial infarction.
Topics: Albuterol; Clinical Trials as Topic; Dopamine; Dose-Response Relationship, Drug; Hemodynamics; Human | 1981 |
Comparison of haemodynamic responses to dobutamine and salbutamol in cardiogenic shock after acute myocardial infarction.
Topics: Aged; Albuterol; Cardiac Output; Catecholamines; Clinical Trials as Topic; Dobutamine; Female; Hemod | 1982 |
3 other studies available for albuterol and Shock, Cardiogenic
| Article | Year |
|---|---|
Recovery from cardiogenic shock complicating right ventricular myocardial infarction.
Topics: Albuterol; Dextrans; Dopamine; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic | 1983 |
Salbutamol in cardiogenic shock complicating acute myocardial infarction.
Topics: Aged; Albuterol; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Card | 1980 |
Haemodynamic effects of salbutamol in patients with acute myocardial infarction and severe left ventricular dysfunction.
Topics: Adult; Aged; Albuterol; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarctio | 1979 |